Sustained release octreotide may have a role in the treatment of malignant bowel obstruction

Palliative Medicine

Volumn 20, Issue 7, 2006, Pages 715-716

  Massacesi, Cristian ^a   Galeazzi, Giordano ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Bowel occlusion; Nasogastric tube; Octreotide; Solid tumors; Vomiting

Indexed keywords

ANALGESIC AGENT; HALOPERIDOL; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG INFUSION; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SECRETION; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE OBSTRUCTION; MALE; MALIGNANT NEOPLASTIC DISEASE; NASOGASTRIC TUBE; NAUSEA; SURVIVAL TIME; SUSTAINED RELEASE FORMULATION; VOMITING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; NAUSEA; OCTREOTIDE; PAIN; RECTAL NEOPLASMS; VOMITING;

EID: 33751234216     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216306070751     Document Type: Article

References (6)

1. Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001; 9: 223-33.
2. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993; 7: 295-99.
3. Ripamonti C, Mercadante S. How to use octreotide for malignant bowel obstruction. Support Oncol 2004; 2: 357-64.
4. Astruc B, Marbach P, Bouterfa H, et al. Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles. J Clin Pharmacol 2005; 45: 836-44.
5. National Cancer Institute. Common toxicity criteria v2.0 (CTC) [online]. Retrieved 1 November 2005, from http://ctep.cancer.gov
6. Mercadante S, Ferrera P, Villari P, Marrazzo A. Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage 2004; 28: 412-16.